Optimizing the implementation of future treatment using surrogate end-points.
Dowsett
Mitch
M
Academic Department of Biochemistry, Royal Marsden Hospital, London, UK. mitch.dowsett@icr.ac.uk
D015415:Biomarkers / Q000032:analysis*; D001943:Breast Neoplasms / Q000378:metabolism / Q000628:therapy*; D049109:Cell Proliferation; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism
D015415:Biomarkers; D019394:Ki-67 Antigen